Drug Trial Radar · NCT06297434
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
87
Actual
Start
Feb 15, 2023
Primary completion
Jun 26, 2025
Study completion Nov 5, 2025
Sponsor
- Lead sponsor
- J2H BiotechIndustry
- Sponsor type
- Industry
- First posted
- Mar 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to evaluate the safety of J2H-1702 compared to the placebo and explore the efficacy of J2H-1702 at Week 12 timepoint after administration compared to baseline in patients with NASH.
Conditions
- Non-alcoholic Steatohepatitis
Interventions
J2H-1702Drug
Orally, once daily before meals
J2H-1702Drug
Orally, once daily before meals
J2H-1702Drug
Orally, once daily before meals
PlaceboDrug
Orally, once daily before meals
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes from baseline in results on MRI-PDFF at week12.Time frame: Baseline and week12
- Changes from baseline in results on MRE at week12.Time frame: Baseline and week12
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Dong-A University Hospital
Busan, South Korea
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
Hallym University Sacred Heart Hospital
Gyeonggi-do, South Korea
Gyeongsang National University Hospital
Gyeongsang, South Korea
Inha University Hospital
Incheon, South Korea
Chung Ang university hospital
Seoul, South Korea
Hanyang University Hospital
Seoul, South Korea
Kyung Hee University Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Seoul St. Mary's Hospital
Seoul, South Korea
Soonchunhyang University Seoul Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.